We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Watson Slams FTC’s Response in Provigil Investigation
Watson Slams FTC’s Response in Provigil Investigation
August 13, 2010
Watson Pharmaceuticals issued a scathing response to FTC assertions that the agency did nothing wrong in its pay-for-delay investigation into the company, saying the commission’s own court-ordered response contradicts that notion.